Correct Answer: 1. Superior vena cava syndrome with facial edema and jugular vein distention
The clinical presentation of this client is highly suggestive of a thoracic malignancy causing compression or obstruction of the
superior vena cava (SVC). In the context of lung cancer, the development of
superior vena cava syndrome (SVCS) represents an oncologic emergency that requires immediate nursing intervention and prompt reporting to the healthcare provider.
Pathophysiology and Clinical Reasoning
The
superior vena cava is a thin-walled, low-pressure vessel responsible for returning venous blood from the head, neck, upper extremities, and upper thorax to the right atrium. In a client with a
30-pack-year smoking history and progressive symptoms, a centrally located lung tumor can cause SVCS through external compression, direct tumor invasion of the vessel wall, or intraluminal thrombosis
[2]. This obstruction leads to increased venous pressure upstream, resulting in the hallmark signs of facial and neck swelling (
edema),
jugular vein distention (JVD), and dilated collateral veins across the chest wall. The client's report of difficulty swallowing (
dysphagia) and facial swelling further supports the presence of a space-occupying lesion in the mediastinum.
Why This Is the Priority
SVCS is a potentially life-threatening condition that can rapidly progress. The obstruction of venous return can lead to cerebral edema, airway compromise from laryngeal or pharyngeal edema, and decreased cardiac output from impaired venous return
[1]. While SVCS is not fatal in the majority of cases, its presence indicates a locally advanced disease state that requires urgent assessment and intervention, such as radiation therapy, chemotherapy, or endovascular stenting, to provide rapid symptomatic relief [1, 3]. The nurse's immediate priority is to recognize these assessment findings, elevate the head of the bed to promote venous drainage, and prepare the client for emergent diagnostic and therapeutic procedures.
Analysis of Other Options
2. Hemoptysis with blood-streaked sputum production
While
hemoptysis is a common and concerning sign in lung cancer due to tumor erosion into bronchial vessels, blood-streaked sputum in small amounts is not typically considered an immediate life-threatening emergency in the same category as SVCS. Massive hemoptysis, which is a volume of about
100-600 mL of blood in
24 hours, would constitute an emergency, but "blood-streaked" sputum indicates a less acute level of bleeding. Nursing intervention is required, but the airway and hemodynamic threat of SVCS takes precedence.
3. Persistent nonproductive cough lasting more than 8 weeks
A persistent cough is a classic, often initial, symptom of lung cancer and is a significant finding that warrants a full diagnostic workup. However, a chronic cough, even one lasting over
8 weeks, is a hallmark of the disease process itself rather than an acute, life-threatening complication. It does not signal the same level of immediate physiological compromise as the venous obstruction seen in SVCS.
4. Unintentional weight loss of 10 pounds over 2 months
Unintentional weight loss is a systemic manifestation of malignancy, often part of a paraneoplastic syndrome or cancer cachexia. A loss of
10 pounds in
2 months is clinically significant and indicates advanced disease, but it represents a chronic metabolic change, not an acute event requiring immediate, moment-to-moment nursing intervention to prevent rapid deterioration. SVCS can be the initial presentation of a previously undiagnosed tumor in up to
60% of cases, making its recognition on initial assessment the most critical finding
[2].
References (research sources)
- [1]
Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report.Case reportHinton J, Cerra-Franco A, Shiue K, Shea L, Aaron V, Billows G, Al-Hader A, Lautenschlaeger T. (2018) · DOI: 10.1186/s13256-018-1843-4
- [2]
Malignant Superior Vena Cava Syndrome: State of the Art.Research articlePatriarcheas V, Grammoustianou M, Ptohis N, Thanou I, Kostis M, Gkiozos I, Charpidou A, Trontzas I, Syrigos N, Kotteas E, Dimakakos E. (2022) · DOI: 10.7759/cureus.20924